YOUNGSTOWN — Elizabeth Zinni, 38, of Paris Drive in Austintown, pleaded guilty Tuesday in Mahoning County Common Pleas Court to two second-degree misdemeanor charges of obstructing official business and was placed on six months of probation for violations related to the Zinni Family Practice, 540 E. Main St. in Canfield.

Visiting Judge W. Wyatt McKay oversaw the plea and sentencing. Zinni was indicted on two counts of sale or use of drugs not approved by the U.S. Food and Drug Administration, which are low level felonies, but she pleaded guilty to misdemeanors.

In addition to the criminal charges, Zinni also was sanctioned by the Ohio Board of Pharmacy last June, according to a June 17, 2025, Ohio Board of Pharmacy document.

The document notified Zinni that the board had suspended the Zinni Family Practice’s license as a distributor of dangerous drugs. It further stated that the Board of Pharmacy found that “based upon the facts set forth” in the document, there is a danger of immediate and serious harm to others due to Zinni Family Practice’s methods used to possess or distribute dangerous drugs.”

The Terminal Distributor of Dangerous Drugs license for the practice was in Elizabeth Zinni’s name, the document states. Zinni is a certified nurse practitioner and registered nurse, according to the state’s eLicense Ohio Licensue Lookup tool, which shows her licenses for both professions to be active.

The Ohio Board of Pharmacy document states that on or about April 21, 2025, a compliance specialist conducted an inspection at the Zinni Family Practice. The inspection revealed that the practice possessed a product labeled in a language other than English, “cloreto de sodio 0,9% IV.” Also found were multiple uncompleted prescription blanks unsecured in a front-desk cabinet and on a counter.

Also found were invoices of drug and device purchases from Jan. 29, 2024, through March 31, 2025, from Vivid-Scientific in North Carolina. Vivid-Scientific is not a licensed TDDD or wholesale distributor of dangerous drugs in Ohio, the document states.

It states that the following drugs were purchased and/or administered to patients that are not FDA approved: Elasty Fine, Elasty Deep, Elasty Grand, Innotox Kit, Innotox, Innotox 100u, Innotox 100u, Revolax Fine, Botulax and Toxta.

The document listed other issues, such as failure to document the temperature in the refrigerator in the lab on Saturdays and Sundays, and the presence of an unopened beverage in the refrigerator in the “medical aesthetics” room.

There were also “multiple expired dangerous drugs in (the) active drug stock, including the following types: Qulipta, expired 11/2023; Inderal XL, expired 4/ 2024; Horizant, expired 12/2024; Saxenda, expired 1/2024; Soliqua, expired 8/31/2024; an opened proparacaine opth solution, expired 6/2023; and Lidocaine, expired 2/1/2025, found in a bin labeled “diabetic syringes with needles, expire 6/2024.”

On or about June 4, 2025, board inspectors conducted a followup inspection and found an opened vial of Liporase, which is not FDA approved, in a refrigerator, and other issues.

The document states that the conduct described potentially violates Ohio laws. Zinni was indicted Oct. 30, 2025, according to court records.